BDWM
GMAB icon

Brewin Dolphin Wealth Management’s Genmab GMAB Stock Holding History

Brewin Dolphin Wealth Management’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-37
Closed -$1K – 361
2022
Q1 		$1K Buy
+37
New +$1.27K ﹤0.01% 367

Other funds holding GMAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HJGA
Hardman Johnston Global Advisors Stamford, Connecticut $2.1B AUM 41.89% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Brewin Dolphin Wealth Management's GMAB Position: Q2 2022 in Review

Brewin Dolphin Wealth Management sold out of Genmab (GMAB) in Q2 2022, closing a stake of 37 shares — an estimated $1K sold.

Brewin Dolphin Wealth Management first reported a position in GMAB in Q1 2022 and held it in 1 quarter. The position peaked at $1K in Q1 2022. 180 funds tracked by Wall St. Rank hold GMAB as of Q2 2022.

  • Brewin Dolphin Wealth Management reported no remaining Genmab position as of Q2 2022 after selling out during the quarter.
  • Brewin Dolphin Wealth Management sold 37 Genmab shares in Q2 2022, an estimated $1K.
  • Brewin Dolphin Wealth Management first reported a position in Genmab in Q1 2022 and held it in 1 quarter.
  • Brewin Dolphin Wealth Management's Genmab position peaked at $1K in Q1 2022.
  • 180 funds tracked by Wall St. Rank held Genmab as of Q2 2022.

Based on Brewin Dolphin Wealth Management's 13F filing for Q2 2022, filed 14 Nov 2022.